Other
Knee Arthroscopy
2
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Knee Arthroscopy is an early-stage landscape with 2 programs across 1 company. The most active players are Resolve Therapeutics. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 32
Approved
No programs
Analysis
Trial Status
23
clinical trials
Completed17 · 74%
Unknown status3 · 13%
Terminated1 · 4%
Recruiting1 · 4%
Not yet recruiting1 · 4%
Clinical Trials
Trial Activity
23 trials
ACB Versus IA Analgesia in Knee Arthroscopy
Completed·—·Phase 2·NCT04715152·72 enrolled
Ultrasound-guided Blocks for Ambulatory Knee Arthroscopy
Completed·—·Phase 4·NCT01837394·60 enrolled
Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy
Completed·—·N/A·NCT01542723·1,500 enrolled
Spinal Anaesthesia for Knee Arthroscopy: Does Lignocaine Shorten the Effect of Bupivacaine
Completed·—·Phase 4·NCT01245868·60 enrolled
Comparison of Hyperbaric Prilocaine With Chloroprocaine for Intrathecal Anaesthesia in Day Case Knee Arthroscopy
Completed·—·Phase 4·NCT03038958·80 enrolled
Using Three Different Doses of Hyperbaric Prilocaine 2% Local Anaesthetic ( 40,50 and 60mg ),Through Spinal Anaesthesia in Knee Arthroscopy Patients to Compare Time to Void
Completed·—·Phase 3·NCT06703580·150 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)